The Memo: Sinaptica Therapeutics Advancing Precision Neuromodulation for Alzheimer’s Disease
Sinaptica was founded to translate over a decade of neuroscience research into a scalable therapy for Alzheimer’s disease. Scientific co-founders.
- By lifescienceintelligence,
- Published on
MootIn.com is a place where you can share your Story/ Product/ Review/ Profile URL and get noticed by the world.
Your ads here